Message from the Director
Eric Orwoll, MD
Welcome to the Oregon Clinical and Translational Research Institute
With major funding from the National Institutes of Health through the Clinical and Translational Science Awards (CTSA), and significant institutional commitment from OHSU, our mission is to improve human health by enhancing clinical and translational research. We are guided by the values of innovation, collaboration, service, excellence and impact.
OCTRI is one of 61 U.S. academic medical centers, all funded by the NIH National Center for Advancing Translational Science, that constitute the Clinical and Translational Science Award (CTSA) Consortium. The Consortium is dedicated to working together to achieve the common goal of advancing clinical and translational research via multi-institutional collaborations.
OCTRI is focused on building clinical and translational research at Oregon Health & Science University, and broadening partnerships with other institutions interested in biomedical issues, including academic institutions, health systems, government and industry. Our intent is to provide a regional platform for clinical and translational research and to create collaborations with a variety of clinical and basic science investigators to maximize our collective ability to stimulate research that is relevant to health. By improving our understanding of health and disease, developing new diagnostics and treatments, and shaping new approaches to the delivery of effective healthcare, OCTRI is bringing science to bear on the lives of our region's citizens and communities.
Team science is important. We are working with our institutional partners to create a broader research support system that nurtures transformative health research by promoting collaborations across institutions and academic units, by streamlining the administrative process of research collaborations, and by leveraging existing resources. All of our efforts aim to enable a diverse group of investigators to more effectively pursue common research goals.
OCTRI has four primary strategic aims:
1. Contributing to major scientific advances in clinical and translational biomedical research. By creating new scientific methodologies and more effective research processes we will contribute to accelerating research both locally and nationally. Moreover, a major focus is to stimulate new scientific discoveries and enable progress on compelling projects, especially those involving transdisciplinary research teams.
2. Building careers in clinical and translational research. OCTRI supports a series of institution-wide curricula and training programs that support the development of the next generation of investigators across the translational spectrum.
3. Providing critical research infrastructures to broadly support institutional, regional and national research efforts in translational research. OCTRI supports every stage of the research process:
- Pilot Project Funding
- Education & Career Development
- Forming a Research Team
- Designing a Study
- Obtaining Regulatory Approval
- Implementing a Study
- Evaluating the Data
4. Continuously critically evaluate the success of our efforts. Using rigorous methods, OCTRI carefully studies its efforts to strategically prioritize resources, ensure productivity and efficiency, and makes appropriate adjustments.
We are excited about the progress made to date, and the opportunities to further accelerate translational science. Please contact me or any of our other staff with any questions, comments or suggestions.
Eric S. Orwoll MD
Professor of Medicine
Director, Oregon Clinical and Translational Research Institute
Associate Dean for Clinical Science, School of Medicine
Associate VP for Clinical Research, OHSU